WILLIAM JOSEPHSON: Open Payments
NPI 1376647651 · NORTHRIDGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,174 in 35 payments from 18 companies in 2025. Trend: 2023 $765 · 2024 $1,295 · 2025 $1,174
Food & beverage: $1,174
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $162 |
| Amgen Inc. | 6 | $144 |
| Neurocrine BioSciences, Inc. | 2 | $135 |
| Exact Sciences Corporation | 1 | $122 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $113 |
| Teva Pharmaceuticals USA, Inc. | 4 | $112 |
| Abbott Laboratories | 3 | $74 |
| Aimmune Therapeutics, Inc. | 2 | $58 |
| PFIZER INC. | 2 | $41 |
| ABBVIE INC. | 1 | $34 |
Products named: CAPLYTA, INGREZZA, The Cologuard Plus Collection Kit, JARDIANCE, AUSTEDO XR, EVENITY, FREESTYLE LIBRE 3, ELIQUIS.
Industry payments across CA — which companies pay providers there.
